We carried out a
controlled study on 240 patients
diagnosed with Peyronie's Disease (PD). We have
divided two treatment groups, which differ from each other only for the
association with PTX-penile injection.
Two groups (A and
B) were totally composed by 160 PD patients (80 patients for each group): Group
A=PTX injection (penile and peri-lesional) 100 mg, every two weeks for six
months + PTX 400 mg /oral/ twice daily + propolis 600 mg / oral / daily +
blueberries 160 mg /oral/ daily + Vitamin E 600 mg / oral / daily + topical
Diclofenac sodium 4% gel / twice a day, for a period of 6 months.
Group B=the same
therapy of group A but without PTX penile injection. Patients who refused
treatment, for various reasons, were included in the control group=Group C
